From: "Bachman, William (MYD)" 
Subject: [NMusers] Addresses for Globomax NONMEM and PDx-Pop Support
Date: 11/3/2003 8:05 PM

As many of you know, GloboMax has been acquired by Icon Clinical Trials.  As
a result of the acquisition, there have been no changes to the GloboMax
infrastructure that will affect NONMEM and PDx-Pop licensing and suppport.
We are also looking forward to continuing our research and development
efforts to continually improve both PDx-Pop and NONMEM.

The support email addresses remain:


PDx-Pop  -

to post to the list -
to be added or removed from the list

Individuals addressses at GloboMax - has changed to

William J. Bachman, Ph.D.
Manager, Pharmacometrics Research and Development
The Strategic Pharmaceutical Development Division of ICON plc
7250 Parkway Drive, Suite 430
Hanover, MD 21076